The Covid-19 Plasma Boom Is Over. What Did We Learn From It?
Health
By BY KATIE THOMAS AND NOAH WEILAND from NYT Health https://ift.tt/3dnhMdr
via IFTTT your-feed-science, Antibodies, Blood Donation, Coronavirus (2019-nCoV), Clinical Trials, Government Contracts and Procurement, Blood, United States Politics and Government, your-feed-healthcare The U.S. government invested $800 million in plasma when the country was desperate for Covid-19 treatments. A year later, the program has fizzled.

By BY KATIE THOMAS AND NOAH WEILAND from NYT Health https://ift.tt/3dnhMdr
via IFTTT your-feed-science, Antibodies, Blood Donation, Coronavirus (2019-nCoV), Clinical Trials, Government Contracts and Procurement, Blood, United States Politics and Government, your-feed-healthcare The U.S. government invested $800 million in plasma when the country was desperate for Covid-19 treatments. A year later, the program has fizzled.
Comments
Post a Comment